Downloaded 893 times
More Related Content
Similar to Indian pharma industry 2014-15
Indian pharma industry 2014-15
- 1.
- 2.
- 3.
- 4.
- 5.
- 6. Indian Pharmaceutical Evolution 6 Phase II GovernmentControl •Indian Patent Act – 1970 •Drug prices capped •Local companies begin to make an impact Phase III Development Phase •Process development •Production infrastructure creation •Export initiatives Phase IV Growth Phase •Rapid expansion of domestic market •International market development •Research orientation Phase V Innovation and Research •New IP law •Discovery Research •Convergence 1970 1980 1990 2000 2010 Phase I Early Years •Market share domination by foreign companies •Relative absence of organized Indian companies
- 7. India Market • Indiasaw its first pharmaceutical company in 1930, Bengal Chemicals and Pharmaceuticals works • Till 1970s Indian pharmaceutical market was non existent • Indian Pharmaceutical market currently stands at approximately 23.6 bn USD** • 10500 manufacturing units, 3000 pharma companies* 7
- 8. Interesting Facts • Brandedgenerics dominate the retail market with 70-80% share • Price levels and margins are low due to intense competition • India ranks 10th globally in terms if value, 3rd in terms of volume • Last 5 years the growth rate is ranging between 13- 14% as compared to 9% before that 8
- 9.
- 10.
- 11. Opportunities • As per'Pharma Vision 2020', the Government of India aims to make India a global leader in end-to-end drug manufacturing** • Manufacturing costs in India are approximately 35-40 per cent of those in the US due to low installation and manufacturing costs** • The biologics market will grow to 3 bn USD by 2020* • The projected human resource requirement in the Indian pharma sector is estimated to be about 21,50,000 by 2020** • Industry Least affected by recession 11
- 12. Opportunities Contd. • Dueto increasing population and income levels, demand for high-end drugs is expected to reach US$ 8 billion by 2015 • Expenditure on pharmaceuticals is likely to increase to over 40 per cent of the total spending on healthcare by households by 2015 from 28 per cent in 2007 • With 70 per cent of India's population residing in rural markets, various pharma companies are investing in the distribution network in rural areas • Increased penetration of chemists, especially in the rural parts of the country would make OTC drugs easily available 12
- 13. Current Top Players- India 13
- 14.
- 15. US Generics Marketshare 15
- 16. Indian impact inUS 16
- 17. Indian Pharma in Specialityproducts 17
- 18.
- 19.
- 20.
- 21.
- 22.
- 23.
- 24.
- 25.